RegenX Science Inc.
regenerative medicine therapies and personalized recovery protocols
- Sector
- Biotech
- Headquarters
- WEST PALM BEACH, FL
- Latest Form D
- $5M, Sep 2022
- Total capital
- $5M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $5M
- 1 Form D · last Sep 2022
- 49 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 0
- 18 pending
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 1st filing$5M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Founders and team
From SEC Form D filings- Elisabeth CorsonExecutive Officer, DirectorNamed in SEC Form D filings
- Jill WaibelDirectorNamed in SEC Form D filings
- Zach FerrellDirectorNamed in SEC Form D filings
- Zheng CaoExecutive OfficerNamed in SEC Form D filings
What it has protected
USPTO · 0 granted of 18- PendingImproved Methods For Decellularizing Extracellular Matrix (ecm) And Preparing Decellularized Ecm Gels And Uses ThereofUSPTOApplication 18837144
- PendingNovel Methods For Decellularizing Extracellular MatrixUSPTOApplication 18837137
- PendingConditioned Water Containing Amphibian Bioactive Molecules And Uses ThereofUSPTOApplication PCTUS2026010790
Show all 18 patent records
- Improved Methods For Decellularizing Extracellular Matrix (ecm) And Preparing Decellularized Ecm Gels And Uses ThereofMay 1, 2025 · Application 18837144Pending
- Novel Methods For Decellularizing Extracellular MatrixMay 1, 2025 · Application 18837137Pending
- Conditioned Water Containing Amphibian Bioactive Molecules And Uses ThereofApplication PCTUS2026010790Pending
- Conditioned Water Containing Amphibian Bioactive Molecules And Uses ThereofApplication 63939332Pending
- Activated Amphibian SkinApplication PCTUS2025038335Pending
- In Vitro Amphibian Cells And Uses ThereofApplication 63745183Pending
- Culture Media Containing Amphibian Bioactive Molecules And Uses ThereofApplication 63745201Pending
- Conditioned Water Containing Amphibian Bioactive Molecules And Uses ThereofApplication 63744632Pending
- Activated Amphibian Cells And Uses ThereofApplication PCTUS2024056920Pending
- Activated Amphibian SkinApplication 63672961Pending
- Activated Amphibian Cells And Uses ThereofApplication 63602257Pending
- Novel Methods For Decellularizing Extracellular MatrixApplication PCTUS2023062398Pending
- Improved Methods For Decellularizing Extracellular Matrix (ecm) And Preparing Decellularized Ecm Gels And Uses ThereofApplication PCTUS2023062405Pending
- Methods For Decellularizing Extracellular Matrix (ecm) And Preparing Decellularized Ecm Gels And Uses ThereofApplication 63267867Pending
- Novel Method For Decellularizing Extracellular MatrixApplication 63267863Pending
- Culture Media Containing Amphibian Bioactive Molecules And Uses ThereofApplication PCTUS2026011283Pending
- Activated Amphibian Cells And Uses ThereofApplication 19589620Pending
- In Vitro Amphibian Cells And Uses ThereofApplication PCTUS2026011279Pending
Related companies, and why
- Stem Cell Reserve, LPSimilar federal contract value in Biotech · null in contracts
- Disket IncSimilar federal contract value in Biotech · null in contracts
- Celltex Therapeutics CorpSimilar federal contract value in Biotech · null in contracts
- EUPRAXIA PHARMACEUTICALS INC.Similar federal contract value in Biotech · null in contracts
- LATTICE THERAPEUTICS INCSimilar federal contract value in Biotech · null in contracts
- Lipocine Inc.Similar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .